Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells

Haifa Shen; Tong Sun; Hanh H. Hoang; Jana S. Burchfield; Gillian F. Hamilton; Elizabeth A. Mittendorf; Mauro Ferrari

doi:10.1016/j.smim.2017.09.002

Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells

Haifa Shen, Tong Sun, Hanh H. Hoang, Jana S. Burchfield, Gillian F. Hamilton, Elizabeth A. Mittendorf, Mauro Ferrari

Research output: Contribution to journal › Review article › peer-review

28 Scopus citations

Abstract

Cancer immunotherapy has become arguably the most promising advancement in cancer research and therapy in recent years. The efficacy of cancer immunotherapy is critically dependent on specific physiological and physical processes – collectively referred to as transport barriers – including the activation of T cells by antigen presenting cells, T cells migration to and penetration into the tumor microenvironment, and movement of nutrients and other immune cells through the tumor microenvironment. Nanotechnology-based approaches have great potential to help overcome these transport barriers. In this review, we discuss the ways that nanotechnology is being leveraged to improve the efficacy and potency of various cancer immunotherapies.

Original language	English (US)
Pages (from-to)	114-122
Number of pages	9
Journal	Seminars in Immunology
Volume	34
DOIs	https://doi.org/10.1016/j.smim.2017.09.002
State	Published - Dec 2017

Keywords

Cancer immunotherapy
Nanotechnology
Tumor microenvironment
Tumor-infiltrating lymphocytes

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.smim.2017.09.002

Cite this

@article{528cd95f6c2547e5b1b2a2252f890152,

title = "Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells",

abstract = "Cancer immunotherapy has become arguably the most promising advancement in cancer research and therapy in recent years. The efficacy of cancer immunotherapy is critically dependent on specific physiological and physical processes – collectively referred to as transport barriers – including the activation of T cells by antigen presenting cells, T cells migration to and penetration into the tumor microenvironment, and movement of nutrients and other immune cells through the tumor microenvironment. Nanotechnology-based approaches have great potential to help overcome these transport barriers. In this review, we discuss the ways that nanotechnology is being leveraged to improve the efficacy and potency of various cancer immunotherapies.",

keywords = "Cancer immunotherapy, Nanotechnology, Tumor microenvironment, Tumor-infiltrating lymphocytes",

author = "Haifa Shen and Tong Sun and Hoang, {Hanh H.} and Burchfield, {Jana S.} and Hamilton, {Gillian F.} and Mittendorf, {Elizabeth A.} and Mauro Ferrari",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Ltd",

year = "2017",

month = dec,

doi = "10.1016/j.smim.2017.09.002",

language = "English (US)",

volume = "34",

pages = "114--122",

journal = "Seminars in Immunology",

issn = "1044-5323",

publisher = "Academic Press",

}

TY - JOUR

T1 - Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells

AU - Shen, Haifa

AU - Sun, Tong

AU - Hoang, Hanh H.

AU - Burchfield, Jana S.

AU - Hamilton, Gillian F.

AU - Mittendorf, Elizabeth A.

AU - Ferrari, Mauro

PY - 2017/12

Y1 - 2017/12

N2 - Cancer immunotherapy has become arguably the most promising advancement in cancer research and therapy in recent years. The efficacy of cancer immunotherapy is critically dependent on specific physiological and physical processes – collectively referred to as transport barriers – including the activation of T cells by antigen presenting cells, T cells migration to and penetration into the tumor microenvironment, and movement of nutrients and other immune cells through the tumor microenvironment. Nanotechnology-based approaches have great potential to help overcome these transport barriers. In this review, we discuss the ways that nanotechnology is being leveraged to improve the efficacy and potency of various cancer immunotherapies.

AB - Cancer immunotherapy has become arguably the most promising advancement in cancer research and therapy in recent years. The efficacy of cancer immunotherapy is critically dependent on specific physiological and physical processes – collectively referred to as transport barriers – including the activation of T cells by antigen presenting cells, T cells migration to and penetration into the tumor microenvironment, and movement of nutrients and other immune cells through the tumor microenvironment. Nanotechnology-based approaches have great potential to help overcome these transport barriers. In this review, we discuss the ways that nanotechnology is being leveraged to improve the efficacy and potency of various cancer immunotherapies.

KW - Cancer immunotherapy

KW - Nanotechnology

KW - Tumor microenvironment

KW - Tumor-infiltrating lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=85029764434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029764434&partnerID=8YFLogxK

U2 - 10.1016/j.smim.2017.09.002

DO - 10.1016/j.smim.2017.09.002

M3 - Review article

C2 - 28947107

AN - SCOPUS:85029764434

SN - 1044-5323

VL - 34

SP - 114

EP - 122

JO - Seminars in Immunology

JF - Seminars in Immunology

ER -

Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this